“Product monopolies and high prices are back in India. The MNCs have started marketing new patented drugs at exorbitant prices particularly for life threatening diseases such as cancer…….” Read more here.
The paper “Multinationals and Monopolies: Pharmaceutical Industry in India after TRIPS” by Prof. Sudip Chaudhury from IIM Calcutta attempts to look at the MNC’s behaviour in post TRIPS scenario to show that days of product monopolies are back in India. Access this paper here
All India Drug Action Network (AIDAN) 